Provided by Tiger Fintech (Singapore) Pte. Ltd.

XOMA Corp

21.18
+0.65003.17%
Post-market: 21.180.00000.00%16:05 EDT
Volume:14.85K
Turnover:312.79K
Market Cap:253.71M
PE:-12.84
High:21.58
Open:20.64
Low:20.59
Close:20.53
Loading ...

XOMA Royalty Corp expected to post a loss of 30 cents a share - Earnings Preview

Reuters
·
14 Mar

XOMA Royalty Corp expected to post a loss of 30 cents a share - Earnings Preview

Reuters
·
04 Mar

XOMA Royalty Corporation's (NASDAQ:XOMA) largest shareholders are retail investors with 38% ownership, institutions own 36%

Simply Wall St.
·
02 Mar

XOMA Royalty to Present at Investor Conferences in March

GlobeNewswire
·
25 Feb

XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

GlobeNewswire
·
04 Feb

XOMA Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
03 Feb

Xoma price target lowered to $104 from $123 at H.C. Wainwright

TIPRANKS
·
03 Feb

XOMA Price Target Maintained With a $123.00/Share by HC Wainwright & Co.

Dow Jones
·
08 Jan

Press Release: XOMA Royalty Declares Quarterly Preferred Stock Dividends

Dow Jones
·
19 Dec 2024

XOMA Price Target Maintained With a $123.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Dec 2024

XOMA Price Target Raised to $123.00/Share From $117.00 by HC Wainwright & Co.

Dow Jones
·
03 Dec 2024

XOMA Royalty Corp - Phase 3 Study for Pulmonary Arterial Hypertension Is Ongoing and Is Expected to Read Out in Q4 of 2025

THOMSON REUTERS
·
02 Dec 2024

XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

THOMSON REUTERS
·
02 Dec 2024

XOMA Royalty Corp - Potential to Net up to $25 Mln in Milestone Payments and Earn a Low to Mid-Single Digit Royalty

THOMSON REUTERS
·
02 Dec 2024

Press Release: XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

Dow Jones
·
02 Dec 2024

Twist Bioscience Corporation (TWST): Among the Best Genomics Stocks to Buy Right Now

Insider Monkey
·
20 Nov 2024

What Makes XOMA Royalty (XOMA) a New Buy Stock

Zacks
·
12 Nov 2024

XOMA Royalty Corporation (NASDAQ:XOMA) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

Simply Wall St.
·
10 Nov 2024

XOMA Royalty Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
09 Nov 2024

XOMA Royalty Corp : Leerink Partners Raises Target Price to $55 From $49

THOMSON REUTERS
·
08 Nov 2024